Stock listing

LSE:VAL ValiRx PLC Share Price

Home listing (LSE) of ValiRx PLC

Follow ValiRx PLC into a list and get an email when it puts out news.

Share price · LSE:VAL

0.14p GBX (pence) -0.00 (-3.4%)

Close on Nov 20, 2026

Past year -39.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.135p – 0.15p GBX (pence)Nov 20, 2026
Volume
31.27M sharesNov 20, 2026
Market cap
£1.85M GBPAt the close on Nov 20, 2026 · price × 1.32B shares outstanding
52-week range
0.12p – 0.48p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£24,871 GBPMedian day 3.87M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
ValiRx PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:VAL · Home0.14p GBX (pence)-0.005 (-3.4%)31,274,0770.147p0.15p0.135p0.145pClose on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:VAL · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
0.14p-0.005-3.4%0.147p0.15p0.135p31,274,077
0.145p-0.005-3.3%0.152p0.152p0.14p6,660,254
0.15p+0.01+7.1%0.133p0.16p0.13p25,916,243
0.14p-0.015-9.7%0.16p0.16p0.135p14,331,913
0.155p-0.005-3.1%0.15p0.156p0.15p1,260,091
0.16p0.000.0%0.159p0.17p0.143p12,244,976
0.16p-0.01-5.9%0.18p0.18p0.15p31,296,629
0.17p+0.03+21.4%0.142p0.18p0.134p36,284,105
0.14p0.000.0%0.13p0.15p0.13p3,761,521
0.14p-0.005-3.4%0.14p0.15p0.13p5,473,163
0.145p-0.015-9.4%0.16p0.16p0.14p29,093,903
0.16p-0.01-5.9%0.172p0.18p0.15p6,449,058
0.17p0.000.0%0.18p0.18p0.16p1,297,396
0.17p0.000.0%0.164p0.18p0.16p10,824,070
0.17p0.000.0%0.177p0.20p0.16p51,713,648
0.17p+0.03+21.4%0.147p0.18p0.13p95,414,368
0.14p+0.005+3.7%0.135p0.15p0.13p20,712,516
0.135p0.000.0%0.14p0.14p0.13p5,080,360
0.135p-0.005-3.6%0.13p0.15p0.13p12,359,989
0.14p0.000.0%0.145p0.15p0.13p19,686,788
0.14p-0.005-3.4%0.145p0.15p0.132p22,248,986
0.145p-0.015-9.4%0.175p0.21p0.14p318,842,015
0.16p+0.03+23.1%0.13p0.19p0.121p151,517,717
0.13p0.000.0%0.13p0.13p0.12p3,869,934
0.13p0.000.0%0.13p0.135p0.12p1,475,119
0.13p0.000.0%0.13p0.14p0.12p732,183
0.13p0.000.0%0.13p0.14p0.12p47,551
0.13p-0.005-3.7%0.135p0.15p0.121p949,497
0.135p0.000.0%0.135p0.15p0.12p3,739,550
0.135p0.000.0%0.135p0.15p0.12p3,778,756
0.135p0.000.0%0.135p0.15p0.12p179,965
0.135p0.000.0%0.135p0.15p0.12p1,664,378
0.135p0.000.0%0.135p0.15p0.121p34,698
0.135p0.000.0%0.135p0.15p0.123p3,004,457
0.135p0.000.0%0.135p0.15p0.12p969,096
0.135p0.000.0%0.135p0.15p0.12p900,905
0.135p+0.01+8.0%0.125p0.138p0.12p6,149,045
0.125p0.000.0%0.125p0.13p0.122p776,850
0.125p0.000.0%0.125p0.13p0.123p4,208,795
0.125p0.000.0%0.125p0.13p0.122p1,141,054
0.125p-0.005-3.8%0.13p0.14p0.12p20,128,568
0.13p-0.005-3.7%0.135p0.14p0.13p4,096,960
0.135p0.000.0%0.135p0.14p0.13p1,002,959
0.135p-0.005-3.6%0.14p0.15p0.13p5,326,975
0.14p0.000.0%0.14p0.15p0.132p1,838,972
0.14p-0.005-3.4%0.145p0.15p0.131p9,541,460
0.145p0.000.0%0.145p0.145p0.14p701,976
0.145p0.000.0%0.145p0.15p0.13p2,161,415
0.145p0.000.0%0.145p0.15p0.141p11,488,627
0.145p0.000.0%0.145p0.15p0.141p984,654
0.145p0.000.0%0.145p0.15p0.14p1,686,659
0.145p0.000.0%0.145p0.15p0.14p7,262,324
0.145p+0.005+3.6%0.14p0.15p0.13p7,029,585
0.14p0.000.0%0.14p0.148p0.132p6,022,000
0.14p0.000.0%0.14p0.15p0.13p1,327,913
0.14p0.000.0%0.14p0.15p0.13p20,032,318
0.14p-0.005-3.4%0.145p0.15p0.13p2,786,069
0.145p-0.01-6.5%0.155p0.16p0.14p16,976,046
0.155p0.000.0%0.155p0.16p0.15p1,623,658
0.155p0.000.0%0.155p0.16p0.15p729,861
0.155p0.000.0%0.155p0.16p0.15p14,692
0.155p0.000.0%0.155p0.16p0.15p183,400
0.155p0.000.0%0.155p0.16p0.155p251,861
0.155p-0.005-3.1%0.16p0.17p0.146p1,624,822
0.16p0.000.0%0.16p0.17p0.15p149,147

Splits

5 splits since 2003 · LSE:VAL · every price before a split is adjusted for it

DayRatioWhat
1-for-125Consolidation
1-for-125Consolidation
1-for-30Consolidation
1-for-2Consolidation
1-for-100Consolidation
Ticker
LSE:VAL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • ValiRx (LSE:VAL) — Investor update presentation

    Tue, Sep 28, 2021 · 8:00 AM ET

    Watch Transcript

Latest news

Update on Ambrose Healthcare shareholding

Oct 21, 2026

Closed 0.145p (-9.4%) on Oct 21, 2026

Half-year Financial Report

Sep 15, 2026

Closed 0.145p (0.0%) on Sep 15, 2026

Cytolytix Patent Update

Aug 10, 2026

Closed 0.16p (0.0%) on Aug 10, 2026

Conclusion of Evaluation with Stingray

Jun 2, 2026

Closed 0.19p (-2.6%) on Jun 2, 2026

Cytolytix Patent Granted

May 27, 2026

Closed 0.20p (+2.6%) on May 27, 2026

Result of Oversubscribed WRAP Retail Offer

May 21, 2026

Closed 0.195p (+2.6%) on May 21, 2026

WRAP Retail Offer for up to £150,000

May 18, 2026

Closed 0.195p (-2.5%) on May 18, 2026

All ValiRx PLC news

Financings

  • Private placement of placing shares with fundraising warrants

    Nov 20, 2025 · US$964,784

    Closed: £740,000 raised · GBX 0.25 a share · Warrants at GBX 0.5 for 36 months · SP Angel Corporate Finance LLP +2

    Dealers: SP Angel Corporate Finance LLP (lead), Shard (co-lead), Shard Capital Partners LLP

    Buyers: Mark Eccleston (36,000,000 new ordinary shares; 7.91% of enlarged share capital)

    Insiders: Directors Mark Eccleston (36,000,000 shares), Cathy Tralau-Stewart, Gerry Desler and Martin Gouldstone (1,200,000 each) bought 39,600,000 new shares in total

    Use of proceeds: R&D on the collaborative pipeline, preclinical development of Cytolytix and VAL201 2.0, and operating costs

    Announced Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025

  • Private placement of subscription shares with fundraising warrants

    Nov 20, 2025 · US$13,038

    Closed: £10,000 raised · GBX 0.25 a share

    Buyers: Cathy Tralau-Stewart (1,200,000 New Ordinary Shares); Gerry Desler (1,200,000 New Ordinary Shares); Martin Gouldstone (1,200,000 New Ordinary Shares)

    Insiders: Directors and persons closely associated subscribed directly; aggregate director participation in the Fundraising is £100,000

    Announced Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025

  • WRAP Retail Offer shares with warrants

    Nov 20, 2025 · US$198,172

    Closed: £152,000 raised · GBX 0.25 a share · 1 warrant at GBX 0.5 for 36 months · Winterflood Securities Limited

    Dealers: Winterflood Securities Limited

    Announced Oct 30, 2025 · Update Oct 30, 2025 · Update Nov 4, 2025 · Closed Nov 20, 2025

  • Broker Offer Shares

    Dec 10, 2024 · US$318,892

    Update: £250,000 · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months · Shard Capital Partners LLP

    Dealers: Shard Capital Partners LLP (lead)

    Buyers: Mark Eccleston (3,076,923 Broker Offer Shares)

    Insiders: CEO Mark Eccleston subscribed for a further 3,076,923 Broker Offer Shares under the Broker Offer, in addition to his participation in the Subscription

    Announced Dec 9, 2024 · Update Dec 10, 2024

  • Private placement of new ordinary shares with warrants

    Dec 9, 2024 · US$1.51M

    Announced: £1.18M · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months · Shard Capital Partners LLP

    Dealers: Shard Capital Partners LLP (lead)

    Use of proceeds: R&D on CytoLytix (formulation, preclinical and combination testing, more cancer types), new evaluation projects, next in-licence and operating costs

    Announced Dec 9, 2024

  • Private placement of new ordinary shares with warrants (Director/PDMR Subscription)

    Dec 9, 2024 · US$178,800

    Announced: £140,000 · GBX 0.65 a share · 1 warrant at GBX 1.3 for 36 months

    Buyers: Mark Eccleston (17,692,307 Subscription Shares (including OncoLytika Ltd and his partner); 5.25% of enlarged share capital); Adrian de Courcey (1,538,461 Subscription Shares); Cathy Tralau-Stewart (769,231 Subscription Shares); Gerry Desler (769,231 Subscription Shares); Martin Gouldstone (769,231 Subscription Shares)

    Insiders: Directors and persons closely associated with them subscribed for 21,538,461 shares (£140,000); a related party transaction under AIM Rule 13

    Announced Dec 9, 2024

Read by 6ix AI from the company's releases

Decks

ValiRx PLC on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 450 in all · newest Oct 21, 2026 · oldest 2000
Calls
1 call with a replay · 1 with a transcript · latest Sep 28, 2021
Decks
4 decks · latest November 2022

Where ValiRx PLC is listed

ListingExchangeCountryCurrency
LSE:VAL · Home listing · This pageLSEUnited KingdomGBX
LS Exchange:A2P1SHLS ExchangeGermanyEUR
Lang & Schwarz:A2P1SHLang & SchwarzGermanyEUR
Frankfurt:EAJFFrankfurtGermanyEUR
Stuttgart:EAJFStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about ValiRx PLC.